ʻO kēia trailer no ke kiʻi paʻi Nā hōʻike o ka hōʻino hiʻohiʻona i kahi mea maʻi me MS e kūkākūkā ana i kona loulou i kāna hoʻopiha ʻana i ka mercury amalgam.
Multiple Sclerosis & Mercury Exposure; Hōʻuluʻulu Manaʻo
ʻO ka sclerosis maha ("MS") ka mea i ʻike pinepine ʻia i ke kenekulia ʻumikūmāiwa i loko o ka manawa i hoʻohana pinepine ʻia ai nā hoʻopiha amalgam. Ua hōʻike ʻia nā hōʻike anecdotal ʻaʻole i paʻi ʻia he helu nui o, akā ʻaʻole naʻe nā mea a pau, nā mea i hōʻino ʻia me kā lākou mercury / kālā i hoʻopau i ka hoʻonā (remanist remission) a hoʻomaikaʻi maikaʻi paha. Ua kākoʻo ʻia kēia hōʻike anecdotal e nā noiʻi i paʻi ʻia i loko o nā makahiki he 50 i hala.
ʻO kahi laʻana, i ka hana i paʻi ʻia ma 1966, ua hoʻoholo ʻo Baasch he sclerosis nunui kahi ʻano mākua o ka acrodynia (maʻi ʻākala) a me kahi neuro-maʻi kūpili i hopena ʻia, i ka hapanui o nā hihia, e ka mercury mai nā hoʻopiha amalgam.1 Ua hōʻike ʻo Baasch i kekahi mau hihia kikoʻī a kuhikuhi i nā noiʻi e hoʻomau ana e hōʻike ana i ka pau ʻana o ka holomua a me ka hoʻomaikaʻi ʻana i ka hoʻonā ʻana o MS ma hope o ka hemo ʻana o nā hoʻopiha amalgam.
I loko o kahi noiʻi kikoʻī i paʻi ʻia ma 1978, ua hōʻike ʻo Craelius i kahi pilina paʻa (P <0.001) ma waena o nā helu make o MS a me nā caries niho.2 Ua hōʻike ka ʻikepili i ka hiki ʻole ke hiki i kēia hoʻopili ʻana ma muli o ka manawa wale. Ua kāpae ʻia nā kumu papaʻai he nui e hāʻawi i nā kumu.
ʻO kahi kuhiakau i hōʻike ʻia e TH Ingalls, MD, i ka makahiki 1983 i noi ʻia e kiʻi lohi, retrograde o ka mercury mai nā aʻa aʻa a i ʻole nā hoʻopiha amalgam e alakaʻi iā MS i ka makahiki waena.3 Ua nānā hou ʻo ia i ka ʻikepili epidemiological ākea e hōʻike ana i ka hoʻopili lalani ma waena o nā helu make mai MS a me nā helu o nā niho pala, nalo, a piha hoʻi. I ka noiʻi i paʻi ʻia ma 1986, ua ʻōlelo ʻo Ingalls e nānā pono nā mea noiʻi i nā kumu o MS e nānā pono i nā moʻolelo niho o nā mea maʻi.4
Ua hoʻomau ʻia kahi mau noiʻi ʻē aʻe e hoʻokumu i ka pilina kūpono ma waena o MS a me mercury. ʻO kahi laʻana, noiʻi e Ahlrot-Westerlund mai 1987 ʻike ʻia he ʻewalu mau manawa o ka poʻe MS i ka pae maʻamau o ka mercury i loko o kā lākou cerebral spinal fluid ke hoʻohālikelike ʻia i nā kaohi olakino neurologically.5
Eia kekahi, ua ʻimi nā kānaka noiʻi ʻo Siblerud lāua ʻo Kienholz o ka Rocky Mountain Research Institute, Inc. i ke kuhiakau e pili ana ka mercury mai nā hoʻopiha amalgam niho i MS i ka hana i paʻi ʻia ma 1994.6 Hoʻohālikelike ia i nā hopena o ke koko ma waena o nā kumuhana MS i kāpae ʻia kā lākou amalgams a me nā poʻe MS me nā amalgams.
Ua loaʻa nā kumuhana MS me nā amalgams i nā pae haʻahaʻa o nā ʻulaʻula, nā hemoglobin, a me nā hematocrit i hoʻohālikelike ʻia me nā poʻe MS me ka hoʻoneʻe ʻana o amalgam. Ua hoʻohaʻahaʻa nui ʻia hoʻi nā pae thyroxine i ka hui amalgam MS, a he pae haʻahaʻa ko lākou o ka nui o nā Lymphocytes T a me nā hunaola suppressor T-8 (CD8). Loaʻa i ka hui amalgam MS ke kiʻekiʻe o ka nitrogen urea koko a me ka IgG serum haʻahaʻa. Ua ʻoi aku ke kiʻekiʻe o ka mercury lauoho ma nā kumuhana MS i hoʻohālikelike ʻia i ka pūʻulu mālama ʻole MS. Ua ʻike ʻia kahi nīnau nīnau olakino ua ʻoi aku ka nui o nā mea MS me amalgams (33.7%) ʻoi aku ka nui ma loko o nā mahina he 12 i hala i ka hoʻohālikelike ʻia me nā manawaleʻa MS me ka hoʻoneʻe ʻana o amalgam. 7
ʻO ke kuleana o ka myelin, kahi mea kōkua i ka lolo e hoʻouna i nā leka i ke kino, kahi mea nui o ka noiʻi MS, a ua hoʻokumu ka MELISA Foundation i ka mea a lākou e manaʻo nei he mea nui i ka hoʻomaopopo ʻana iā MS ma ka ʻike ʻana i ka loulou ma waena o nā mea āpau a me ka ʻaʻai. o myelin. I ka noiʻi i paʻi ʻia ma 1999, Ua ʻōlelo ʻo Stejskal lāua ʻo Stejskal ua hoʻāla ʻia nā hopena hypersensitive e nā mea hao e komo ana i ke kino o ke kanaka āpau i ka metala i nīnau ʻia.8 Hoʻopili kēia mau mea i ka myelin, hoʻololi iki i kāna ʻano protein. I ka poʻe hypersensitive, ʻike hewa ʻia ke ʻano hou (myelin a me ka huna keleawe) ma ke ʻano he komo haole a hoʻouka ʻia (kahi pane autoimmune) ʻO ka lawehala ka "myelin plaques" i ka lolo, i maʻa mau i nā mea maʻi me MS. ʻO ia mau plake hiki ke hopena o ka allergy metala. Hoʻomaka koke ka MELISA Foundation e palapala i nā poʻe maʻi me nā pilikia autoimmunity e hana i kahi ʻāpana a, i kekahi mau hihia, hoʻōla piha ʻia e ka lawe ʻana i ke kumu o nā metala-pinepine ka hoʻopiha niho.9
ʻO kahi noiʻi cohort retrospective e Bates et al. i paʻi ʻia ma 2004 i loko o ka nānā ʻana i nā moʻolelo lapaʻau o 20,000 poʻe ma ka New Zealand Defense Force (NZDF).10 Ua manaʻo nā mea noiʻi e ʻimi i nā loulou kūpono ma waena o ka amalgam niho a me nā hopena olakino, a ʻo kā lākou mea i loaʻa ai i alakaʻi ʻia ai e hōʻike i kahi hui "ikaika" ma waena o MS a me ka hōʻike ʻana o amalgam niho. Eia kekahi, ʻekolu mau paʻi noiʻi hihia MS i paʻi ʻia ma mua i hoʻopaʻa ʻia ʻaʻohe hui nui me nā hoʻopiha mercury amalgam niho11 12 13 ʻike ʻia e Bates et al. e like me nā palena like ʻole. ʻOiai ʻoi aku ka kikoʻī, ua ʻōlelo ʻo Bates a me kāna mau hoa hana he hoʻokahi wale nō o ia mau noiʻi ʻekolu i hoʻohana i nā hihia hanana a me nā moʻolelo niho, a ua hana maoli ʻia ua hōʻike like nei i nā manaʻo loiloi kiʻekiʻe loa no ka nui o nā hoʻopiha mercury amalgam.14
Ua mālama ʻia kahi loiloi ʻōnaehana o nā puke e pili ana i ka amalgam niho a me nā sclerosis he nui e nā kānaka noiʻi Kanada a paʻi ʻia ma 2007.15 ʻOiai Aminzadeh et al. ua hōʻike i ka likiki o ka pilikia o MS ma waena o nā mea lawe amalgam i kūlike ʻole, ua ʻōlelo lākou he piʻi iki a me ka helu ʻole. Eia nō naʻe, ua ʻōlelo lākou i nā palena o kā lākou hana ponoʻī a ua paipai hoʻi i nā noiʻi e hiki mai ana e noʻonoʻo i nā kumu ʻē aʻe e like me ka nui o ka amalgam, ka ʻili o ka ʻili, a me ka lōʻihi o ka hōʻike ʻana ke nānā hou i kekahi loulou ma waena o ka amalgam niho a me MS.
He kanahikukumamāhā mau maʻi me MS a me kanahikukumamāhā mau mea manawaleʻa olakino nā kumuhana o kahi aʻo Iran e Attar et al. paʻi ʻia ma 2011.16 Ua ʻike nā kānaka noiʻi ua ʻoi aku ke kiʻekiʻe o ka pae mercury serum i nā maʻi MS ma mua o nā kaohi. Ua manaʻo lākou ʻo ka pae kiʻekiʻe o ka mercury i ke serum ke lilo i kumu i maʻalahi ʻia i nā sclerosis he nui.
I ka 2014, ʻo Roger Pamphlett o ke Kulanui o Sydney ma Australia ua loaʻa i kahi kuhiakau olakino i paʻi ʻia e pili ana i nā mea ʻona i pili i ke kaiapuni, e like me ka mercury, i nā maʻi o ka ʻōnaehana waena.17 Ma hope o ka wehewehe ʻana i ka hopena i nā lāʻau ʻona a me ka hopena o ke kino, ua noi ʻo ia: a me ka psychiatric (kaumaha nui a me nā maʻi bipolar) nā kūlana. "18
Ua hōʻike ʻia kahi noiʻi i paʻi ʻia ma 2016 i hōʻiliʻili ʻo Pamphlett i nā hōʻike e kākoʻo i kāna kuhiakau. Ua aʻo ʻo ia a me kekahi hoa hana i nā laʻana o ka iwi kuamoʻo mai 50 poʻe mai ka makahiki 1-95.19 Ua ʻike lākou he 33% o ka poʻe 61-95 mau makahiki i loaʻa nā metala kaumaha i loko o kā lākou interneurons ʻōiwi (ʻoiai ʻaʻole nā makahiki ʻōpio). Ua alakaʻi ʻia ka noiʻi iā lākou e hoʻopau: "ʻO ka hōʻino ʻana i nā interneurons kaohi mai nā mea ʻawaʻawa i ke ola hope e hopena i ka hōʻeha excitotoxic i nā motoneuron a hiki i ke kumu o ka hōʻeha motoneuron a i ʻole nā nalowale i nā ʻano e like me ALS / MND, sclerosis maha, sarcopenia a me nā pīpī pipiʻi."20
ʻO kekahi noi i paʻi ʻia ma 2016, mai nā mea noiʻi ma ke Kulanui o North Carolina, nā Centers for Disease Control and Prevent, a me ke Kulanui ʻo Duke, ua nānā pū kekahi i ka loulou kūpono ma waena o nā metala kaumaha a me nā sclerosis he nui.21 217 mau kānaka me MS a me 496 kāohi i hoʻokomo ʻia i loko o ka hoʻopaʻa hihia hihia hihia lehulehu, i hoʻolālā ʻia e loiloi i ka pilina ma waena o ka hopena i ke kēpau, mercury, a me nā mea hoʻoheheʻe a me 58 polymorphism nucleotide hoʻokahi i loko o nā genes pili i ka MS. Napier ma. ʻike ʻia he ʻoi aku ka nui o ka poʻe me MS ma mua o nā kaohi e hōʻike i ke alakaʻi a me ka mercury.
He mea nui nō hoʻi e hoʻomaopopo i ka nui o nā mōʻaukala hihia i paʻi ʻia i loko o nā makahiki he 25 i hala aku nei, me ka hoʻohui ʻia o kekahi o nā noiʻi i ʻōlelo ʻia ma luna, ua palapala i ka hiki no nā mea maʻi MS ke ʻike i nā pae like ʻole o ka hoʻomaikaʻi olakino ma hope o ka hemo ʻana o kā lākou hui ʻana i ka amalgam. Ua hōʻike ʻia nā noiʻi a Redhe a me Pleva i paʻi ʻia ma 1993 i ʻelua mau laʻana mai 100 mau hihia ahonui e loiloi ana i nā hopena pale maʻi o ka amalgam niho.22 Ua ʻōlelo lākou e hemo ka amalgam i nā hopena maikaʻi i kekahi mau hihia o MS. Ma kahi ʻano ʻē aʻe, ua aʻo ʻia e Huggins a me Levy i paʻi ʻia ma 1998 i hōʻike ʻia i ka hemo ʻana o nā amalgams niho, ke mālama ʻia me nā lāʻau lapaʻau ʻē aʻe, ua hoʻololi i nā ʻano photolabeling o nā protein fluid cerebrospinal i kēlā me kēia kanaka me MS.23
Hāʻawi kekahi mau hiʻohiʻona ʻē aʻe i nā hōʻike e pili ana i nā pono kūpono o ka hoʻoneʻe ʻana o amalgam i nā mea maʻi MS. Ua noiʻi ʻia mai ka MELISA Foundation i paʻi ʻia ma 2004 loiloi i nā hopena olakino o ka hoʻoneʻe ʻana o amalgam i nā mea mercury-maʻi me nā autoimmunity, a ʻo ka helu kiʻekiʻe loa o ka hoʻomaikaʻi i loaʻa i nā maʻi me MS.24 Hoʻohui ʻia, ua paʻi ʻia kahi moʻaukala hihia i ka makahiki 2013 mai nā mea noiʻi ʻItalia i kākau ʻia he mea hoʻomanawanui me MS i hoʻopau ʻia ka piha i ka mercury a laila ua hoʻomaikaʻi ʻia kahi chelation therapy (kahi ʻano detoxification) i hoʻomaikaʻi ʻia.25 ʻO nā kānaka noiʻi, ua pili kekahi o lākou me ka Ministry of Health i ʻItalia, ua kākau ʻo ia ka hōʻike i hōʻike ʻia e "hōʻoia i ke kuhiakau o TMP [lāʻau make mea ʻawaʻawa] ma ke ʻano he mea hoʻopuni kaiapuni a iatrogenic paha no MS, keu hoʻi ke waiho pono ʻole ka detoxification ma ka kumu. ” 26
ʻOiai ʻoi aku ka noiʻi e pono ai e hoʻoholo i ka piha o ka pilina ma waena o ka mercury a me MS, nā puke ʻepekema i paʻi ʻia i loko o nā makahiki he 50 i hala aku nei e hoʻomau nei e hōʻike i ka hōʻike ʻana o ka mercury mai nā amalgams niho, a me nā ʻano mercury haʻahaʻa haʻahaʻa ʻē aʻe. e noʻonoʻo koʻikoʻi no kahi kuleana i ka etiology o MS. Pono e hoʻomanaʻo ʻia he hana like nā hōʻike ʻona ʻē aʻe i kōkua i ka wehewehe ʻana i ke kumu o ka loaʻa ʻole o kahi mercury amalgam pani pani niho a kekahi mau mea maʻi MS paha. ʻO kahi laʻana, kahi noiʻi i paʻi ʻia ma 2016 e nā mea noiʻi ma Taiwan e hoʻopili iā MS e alakaʻi i ka lepo.27
He mea nui nō hoʻi e hoʻomanaʻo i ka laulā, ʻo ka noiʻi hou loa e hōʻike nei i ka nui o ka causation o MS he multifactorial. No laila, hiki ke nānā aku i ka mercury ma ke ʻano he hoʻokahi wale nō mea i loko o kēia maʻi, a me nā hōʻike ʻino ʻē aʻe, nā ʻano genetika, ke kū ʻana o nā maʻi ʻākela, a me kekahi mau hanana hou aʻe i hoʻokau i ke kuleana ma MS pū kekahi.
Loaʻa i ka IAOMT kekahi mau kumuwaiwai hou aʻe e pili ana i kēia kumuhana.
Nā Mea kākau ʻatikala ʻo Mercury niho
Ua hoʻomaʻamaʻa ʻo Kauka David Kennedy i ka niho niho no nā makahiki he 30 a ua haʻalele ʻo ia mai ka hana lapaʻau ma 2000. ʻO ia ka Pelekikena mua o ka IAOMT a ua aʻo ʻo ia i nā kauka niho a me nā ʻoihana olakino ʻē aʻe a puni ka honua e pili ana i nā kumuhana o ke olakino niho preventive, mercury toxicity, a me ka fluoride. Ua ʻike ʻia ʻo Kauka Kennedy ma ke ao holoʻokoʻa ma ke ʻano he kākoʻo no ka wai inu palekana, lāʻau lapaʻau olaola a he alakaʻi i ʻike ʻia ma ke kahua o ka mālama niho pale. ʻO Kauka Kennedy ka mea kākau a me ke alakaʻi o ka kiʻiʻoniʻoni palapala lanakila lanakila ʻo Fluoridegate.